FHLCFidelity MSCI Health Care Index ETF

Grow my money12y track recordRanked #161 of 2,992 in this goal

Tracks the MSCI USA IMI Health Care 25/50 Index.

By Fidelity Investments · Launched 2013

Annual Cost

0.08%

#307 of 5,854 · low cost

Fund Size

$3.2B

#566 of 5,854 · large

Return (1Y)Goal

+25.3%

Track Record

12 years

#1,113 of 5,854 · established

Performance

Total-return NAV · USD

Growth of $10,000

$12,026+20.3%

Total-return NAV, USD. Net of fund fees, before tax.

What's inside

How Beacon categorizes this fund

Asset class

Equity

Region

North america

Cap

Multi cap

Strategy

Index tracking

Sector

Health care

Focus

Biotech & Genomics

Index tracked

MSCI USA IMI Health Care 25/50 Index

What it actually holds

By weight

Concentration

Top 10 holdings = 50.6% of fundmoderately concentrated

Eli Lilly & Co

12.1%

Johnson & Johnson

8.9%

AbbVie Inc

6.0%

UnitedHealth Group Inc

5.4%

Merck & Co Inc

4.4%

Amgen Inc

3.0%

Thermo Fisher Scientific Inc

2.9%

Gilead Sciences Inc

2.6%

Intuitive Surgical Inc

2.6%

Abbott Laboratories

2.5%

Asset allocation

Stocks

99.9%

Cash

0.1%

By sector

Healthcare

100.0%

Financial Services

0.0%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years

Volatility (1Y)

15.4%Moderate

Year-on-year price swings

Max drawdown

-28.8%Moderate

Worst peak-to-trough loss

Sharpe (3Y)

0.39Below average

Sortino (3Y)

0.56Moderate downside risk

Listing

Exchange: NYSE Arca

Full fund details

Objective: Tracks the MSCI USA IMI Health Care 25/50 Index.
Strategy: Invests primarily in securities included in the MSCI USA IMI Health Care 25/50 Index, representing the U.S. health care sector. Uses a representative sampling indexing strategy to manage the fund, focusing on companies involved in health care equipment, services, pharmaceuticals, and biotechnology.
Inception date: October 21, 2013
Fund family: Fidelity Investments